Skip to main content

CivaSheet Bio-Compatibility Studies

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Feb 21, 2012
Award amount: 
$249,048
Organization name: 
CivaTech Oncology Incorporated
Principal Investigator: 
Hoedl, Seth A.
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

PUBLIC INFORMATION SUMMARY
This project will partially support the bio-compatibility studies of the CivaSheet. This product provides radiation therapy in a novel way -- cancerous tissue is exposed to radiation while healthy tissue is not. The product is specifically designed to treat lung cancer, although other cancers could be treated as well. The funds from the SRL will be used to demonstrate the bio-compatibility of the CivaSheet and will lay the foundation for FDA approval.

Fiscal year: 
2012